The latest price target for Scotts Miracle Gro (NYSE:SMG) was reported by UBS on January 16, 2025. The analyst firm set a price target for $72.00 expecting SMG to rise to within 12 months (a possible 2.52% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for Scotts Miracle Gro (NYSE:SMG) was provided by UBS, and Scotts Miracle Gro maintained their neutral rating.

The last upgrade for The Scotts Miracle Gro Co happened on July 11, 2023 when Truist Securities raised their price target to N/A. Truist Securities previously had a hold for The Scotts Miracle Gro Co.

The last downgrade for The Scotts Miracle Gro Co happened on April 5, 2024 when Truist Securities changed their price target from $65 to $75 for The Scotts Miracle Gro Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Scotts Miracle Gro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Scotts Miracle Gro was filed on January 16, 2025 so you should expect the next rating to be made available sometime around January 16, 2026.

While ratings are subjective and will change, the latest Scotts Miracle Gro (SMG) rating was a maintained with a price target of $77.00 to $72.00. The current price Scotts Miracle Gro (SMG) is trading at is $70.23, which is out of the analyst’s predicted range.